Back to search results
  • Search opportunities
  • Search results
  • Opportunity details

Cancer Voices: Help review the use of AI to support prostate cancer care

Opportunity image

Through Macmillan's Innovation Impact Investment Portfolio, Macmillan’s Innovation Engagement Team are working in partnership with Lucida Medical, a company that develops Artificial Intelligence (AI) based software to assist radiologists in detecting cancer accurately, consistently, and quickly.

Lucida's first AI tool supports the analysis of MRI scans for prostate cancer diagnosis. The Innovation Team is looking to involve people with lived experience of prostate cancer to review what Lucida Medical are working to achieve and to help them understand attitudes towards the use of AI to support the prostate cancer pathway. They will explore these perceptions and discuss the challenges and opportunities that AI presents within this area in a focus group taking place on Thursday 1st August.

For this project, we would like to involve people from across the UK who have:

  • A lived experience of prostate cancer.
  • Supported a family or friend through a prostate cancer diagnosis.
  • Had investigations for possible prostate cancer - this may not have resulted in a cancer diagnosis.

If you are interested in taking part in this focus group, please read the full project overview document. Within the document you will find more details about the project, as well as a link to a short expression of interest form. The deadline for expressions of interest is Wednesday 17th July 2024. You should expect to hear back from Hannah or Lucie in Macmillan’s Innovation Engagement Team by the end of Friday 19th July.